Jun 3, 2018

EPA taps former chemical industry attorney to head Superfund group

The Gowanus Canal, a designated federal Superfund site in Brooklyn, New York. Photo by Spencer Platt/Getty Images)

The Environmental Protection Agency’s task force that oversees the cleanup of some of the country's most contaminated sites, will be led by a former lawyer for a plastics and chemicals company, the AP reports.

Why it matters: Steven Cook, the new chair of the Superfund Task Force, has reportedly worked more than 20 years as a corporate counsel for LyondellBasell Industries — one of the country’s largest plastics, chemicals and refining companies that the EPA has suspected of polluting some three dozen sites.

The details: The task force is overseeing the cleanups of more than 1,300 toxic sites. The AP reports that Cook signed a memo in April recusing himself from regulatory matters involving LyondellBasell. But he’s allowed to participate in matters involving the company if the decision would also affect five or more other companies.

  • Cook joined the agency in February as deputy assistant administrator for EPA’s Office of Land and Emergency Management.

What they're saying: Agency spokesman Lincoln Ferguson told the AP: "All EPA employees receive ethics briefings when they start and continually work with our ethics office regarding any potential conflicts they may encounter while employed here. Steven Cook is no different."

  • Pattie Shieh-Lance, a LyondellBasell spokeswoman, told the AP the company has "resolved its Superfund obligations nearly a decade ago" and it "does not currently have any such obligations."

The bigger picture: An AP analysis found that nearly half the EPA's political appointees under the current administration have close industry ties. Of the more than 60 hires tracked last year, the publication said about one-third worked as registered lobbyists or attorneys for chemical companies, fossil fuel manufacturers or other EPA-regulated companies.

Go deeper

Pandemic forces startups to shift gears

Illustration: Eniola Odetunde/Axios

Spaces CEO Brad Herman had an early warning about COVID-19 because his startup supplies VR attractions to a number of theme parks in China. Realizing that the business he spent the last few years building was going to evaporate, Herman quickly found a new way to apply his team's know-how: helping companies host Zoom teleconferences in VR.

Why it matters: Many startups are rethinking the viability of their core businesses in the wake of the coronavirus. Spaces' move is one of many such pivots likely to crop up in the coming months.

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

Go deeperArrow56 mins ago - Health

We can't just flip the switch on the coronavirus

Illustration: Sarah Grillo/Axios

It feels like some big, terrible switch got flipped when the coronavirus upended our lives — so it’s natural to want to simply flip it back. But that is not how the return to normalcy will go.

The big picture: Even as the number of illnesses and deaths in the U.S. start to fall, and we start to think about leaving the house again, the way forward will likely be slow and uneven. This may feel like it all happened suddenly, but it won't end that way.